Bringing the fundamentals into focus…
Back to Collegium Pharmaceutical, Inc.
How Collegium Pharmaceutical, Inc. stacks up
COLL · against 437 other Healthcare companies of similar size
Growth
68/ 100
Above the middle of the pack.
Ranked #127 of 438 · scores higher than 70% of peers
Bars: peers in each 10-point band of the growth score44 peers with a growth score of 60–69, including COLL · Click a bar to see the companies
Why growth scores 68?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- faster growth in earnings per share: stronger than 68% of peers. Earnings per share growth: 28.8% vs peer median 9.8%
- faster revenue growth over the last year: stronger than 70% of peers. Revenue growth: 14.3% vs peer median 6.1%
- faster revenue growth over three years: stronger than 73% of peers. 3-year revenue growth: 14.6% vs peer median 5.8%
Metric by metric
Position: dot = COLL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | COLL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 448 reported | 14.3% | 3.7% | 74% | 33% | |
| Earnings per share growthHigher is better · 242 reported | 28.8% | 5.5% | 72% | 33% | |
| 3-year revenue growthHigher is better · 431 reported | 14.6% | 4.6% | 74% | 33% |
Ranking by growth score
Top 5 and the companies ranked around COLL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 120 | 504M USD | 69 | 24 | |
| 127 | 585.5B KRW (≈$422M) | 68 | 63 | |
| 127 | 8.0B CNY (≈$1.1B) | 68 | 58 | |
| 127 | 6.1B HKD (≈$775M) | 68 | 49 | |
| 127 | 773M USD | 68 | 64 | |
| 131 | 4.5B HKD (≈$579M) | 67 | 54 | |
| 131 | 62.7B JPY (≈$426M) | 67 | 40 | |
| 131 | 693M EUR (≈$763M) | 67 | 70 | |
| 134 | 9.3B CNY (≈$1.3B) | 66 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score